Skip to main content
Transition Therapeutics Inc. logo

Transition Therapeutics Inc. — Investor Relations & Filings

Ticker · TTH ISIN · CA8937162094 TSX Professional, scientific and technical activities
Filings indexed 137 across all filing types
Latest filing 2016-10-11 Regulatory Filings
Country CA Canada
Listing TSX TTH

About Transition Therapeutics Inc.

https://www.transitiontherapeutics.com

Transition Therapeutics is a biopharmaceutical company dedicated to the research and development of novel therapeutic agents for disease indications with large global markets. The company focuses on developing small molecule therapeutics primarily targeting CNS (Central Nervous System) and metabolic diseases, including treatments for Alzheimer's disease and diabetes. Its pipeline includes a lead drug candidate that has completed Phase II clinical trials.

Recent filings

Filing Released Lang Actions
Notice (amended).pdf
Regulatory Filings
2016-10-11 English
Notice.pdf
Regulatory Filings
2016-09-15 English
Material change report - English.pdf
Regulatory Filings
2016-09-09 English
News release - English.pdf
Regulatory Filings
2016-08-26 English
Report of voting results.pdf
Regulatory Filings
2016-08-26 English
Form of proxy - English.pdf
Regulatory Filings
2016-08-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.